Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-30

FDA Approved: TRANDOLAPRIL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for Trandolapril from Aurobindo Pharma Limited, authorizing the marketing of a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trandolapril (trandolapril)

Snippet

SUPPL AP for TRANDOLAPRIL (TRANDOLAPRIL)